summary
Introduced
01/23/2017
01/23/2017
In Committee
01/23/2017
01/23/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
190th General Court
Bill Summary
Relative to the use of epinephrine, adrenaline or other agents by optometrists in the treatment of anaphylaxis. Public Health.
AI Summary
This bill aims to expand the scope of practice for optometrists in Massachusetts. It allows qualified optometrists to utilize and prescribe a broader range of therapeutic pharmaceutical agents, including those in Schedules III, IV, V, and VI, for the purpose of diagnosing, preventing, correcting, managing, or treating ocular diseases and abnormalities. The bill also authorizes optometrists to use epinephrine, adrenaline, or other agents for the percutaneous treatment of anaphylaxis. Additionally, it establishes new certification and continuing education requirements for optometrists to qualify for this expanded scope of practice.
Committee Categories
Health and Social Services
Sponsors (19)
Jay Barrows (R),
Nick Boldyga (R),
Angelo D'Emilia (R),
Geoffrey Diehl (R),
Kim Ferguson (R),
Paul Frost (R),
Susan Gifford (R),
Sheila Harrington (R),
Steven Howitt (R),
Randy Hunt (R),
Brad Jones (R),
Hannah Kane (R),
Kevin Kuros (R),
Matt Muratore (R),
Shaunna O'Connell (R),
Keiko Orrall (R),
Elizabeth Poirier (R),
Todd Smola (R),
Dave Vieira (R),
Last Action
Accompanied H1169 (on 03/09/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/190/H1174 |
| Bill | https://malegislature.gov/Bills/190/H1174.pdf |
Loading...